The North America Vascular Stent Market was valued at USD 3,090 Million in 2025 and is expected to reach USD 6,830 Million by 2035, expanding at a CAGR of 7.5% from 2024 to 2035. The market is being driven by advancements in stent technology and a growing geriatric population suffering from cardiovascular diseases.
The economic impact of tariffs on "North America Vascular Stent Market".
Market Growth Drivers
Technological Advancements in Stent Design: Companies like Boston Scientific are pushing the boundaries of vascular stent technology by developing drug-eluting and bioresorbable stents. These innovations have enhanced stent safety and reduced restenosis rates, making them more appealing to both physicians and patients. For instance, the recent release of Boston Scientific’s Synergy Megatron bioresorbable polymer stent has led to faster healing times and improved clinical outcomes. Such advancements drive market demand as healthcare providers seek to offer cutting-edge solutions.
Rising Prevalence of Cardiovascular Diseases: The increasing incidence of conditions like coronary artery disease and peripheral artery disease across North America is fueling demand for vascular stents. Medtronic, for example, has seen significant growth in its stent portfolio owing to the aging population and lifestyle-related risk factors. As awareness and screening improve, more patients are being diagnosed and treated with vascular stent implantation, further accelerating market growth.
Market Trends
Emergence of Minimally Invasive Procedures: There is a notable shift towards minimally invasive vascular interventions in the region. Companies such as Abbott are investing heavily in next-generation delivery systems that facilitate easier, safer, and more efficient stent placement. The trend towards less invasive procedures is driven by patient preference for shorter recovery times and lower complication risks, thereby increasing the adoption rate of vascular stents.
Adoption of Artificial Intelligence (AI) & Digital Health for Patient Management: Integration of AI-powered imaging and patient data analysis tools is becoming a key trend in the vascular stent market. Terumo Corporation recently launched a suite of AI-based vascular imaging solutions to aid cardiologists in stent sizing and positioning for optimal outcomes. This digital transformation is making vascular stent procedures safer, more precise, and cost-effective, creating opportunities for players across the North American market.
Market Opportunities
Expansion in Ambulatory Surgical Centers (ASCs): The growing shift towards outpatient care offers significant opportunities for vascular stent device manufacturers. Companies like Cardinal Health are partnering with ASC networks to provide tailored solutions, capitalizing on the expanding patient base seeking convenient, lower-cost stenting procedures.
Untapped Rural and Remote Healthcare Markets: Large segments of North America's rural population remain underserved due to limited access to advanced cardiovascular care. Expanding distribution and training programs in these regions offers manufacturers like Cook Medical a chance to gain first-mover advantage while improving healthcare outcomes.
North America Vascular Stent Market Revenue (USD Million), 2020-2035
The market revenue chart illustrates a steady upward trajectory for the North America Vascular Stent Market between 2020 and 2035. Starting at USD 1,850 Million in 2020, the market exhibits consistent annual growth, reaching USD 3,090 Million by 2025 and projected to attain USD 6,830 Million by 2035. Key factors driving this expansion are technological innovations, a rising geriatric population, and improved healthcare access. The forecast suggests that the market will nearly double between 2025 and 2035, underscoring strong growth potential for existing and new industry participants. Companies investing in research and development, digital health integration, and rural outreach are likely to benefit most from the anticipated surge in demand.
North America Vascular Stent Market Share by Region (%) - 2025
The 2025 market share pie chart reveals that the United States dominated the North America Vascular Stent Market, accounting for around 71% of the total market. Canada held the second-largest share at 18%, followed by Mexico at 8%. The Central America region accounted for 2%, while the Caribbean region held a marginal 1% share. The dominance of the U.S. is attributed to its advanced healthcare infrastructure, greater adoption of technological innovations, and substantial R&D investments by leading manufacturers. Canada and Mexico’s growing market shares reflect increasing government support and improving healthcare access in these regions.
Recent Developments in the North America Vascular Stent Market (Last 6 Months)
In March 2024, Boston Scientific announced FDA approval for its next-generation Synergy XD drug-eluting stent platform. The new stent is specifically designed for complex coronary artery interventions and boasts enhanced deliverability and vessel conformability. The product launch strengthens Boston Scientific’s market presence and is expected to accelerate its sales in the U.S. over the coming years.
In February 2024, Medtronic completed the acquisition of Avenu Medical, further expanding its vascular portfolio with less invasive AV fistula creation technology for dialysis patients. This move enables Medtronic to offer a broader range of vascular solutions and leverage cross-selling opportunities within the North American market.
In January 2024, Abbott launched a pilot program integrating artificial intelligence-driven imaging tools into its vascular interventional suite. Partnering with leading hospitals in the U.S. and Canada, Abbott’s new system helps clinicians optimize stent sizing and placement, reducing procedure time and improving patient outcomes. The program is anticipated to facilitate wider adoption of AI-driven solutions in vascular stenting procedures.
Press Releases